Opportunity Information: Apply for PA 18 601
The National Institutes of Health (NIH) funding opportunity titled "Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional)" (Funding Opportunity Number PA-18-601) supports small, focused research projects that improve understanding of how sex and gender influence substance use, misuse, abuse, and dependence. Using the NIH R03 mechanism, the program is designed to back early-stage, targeted studies that can generate pilot data, test a clear hypothesis, or explore a promising new direction that could later be expanded into larger-scale research. Clinical trials are allowed but not required, meaning applicants may propose either preclinical or clinical work as long as it fits the aims of the announcement.
The opportunity has two main goals. First, it seeks to strengthen the identification of male-female differences in drug and alcohol research outcomes, clarify the biological and behavioral mechanisms driving those differences, and encourage translational efforts that connect basic science findings to clinical or public health relevance. This could include work that links sex-related biology (for example, hormones, neurobiology, pharmacokinetics, genetics, or immune responses) to observed differences in substance-related behaviors, treatment response, relapse risk, adverse effects, or comorbid conditions. Second, it aims to advance research that is specifically focused on women or is especially relevant to women, recognizing that women may have distinct risk factors, trajectories of use, barriers to care, treatment needs, and health consequences related to alcohol and drug exposure.
A key feature of the announcement is its broad scope. The FOA encourages both preclinical and clinical studies across essentially all areas of drug and alcohol research, as long as the scientific questions meaningfully address sex differences, gender-related factors, or women-focused issues. In practical terms, this could involve studies on prevention, etiology, neurocircuitry, behavioral mechanisms, medication development, psychosocial interventions, recovery processes, or the interaction of substance use with mental and physical health conditions. The emphasis is on improving the evidence base so that research findings, interventions, and clinical guidance are not overly generalized from one sex or gender group to another when meaningful differences exist.
The grant is categorized as a discretionary grant program under the health-related CFDA listings 93.273 and 93.279 and is administered by NIH. The listed award ceiling is $50,000, reflecting the small grant nature of the R03 mechanism. While the source data includes an original closing date of 2021-05-07, the core takeaway for applicants is the program intent: to fund concise, well-justified studies that can quickly advance the field's understanding of sex/gender differences and women-specific issues in substance use research.
Eligibility is intentionally broad, spanning many types of organizations and institutions. Eligible applicants include state, county, city or township, and special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofit organizations with or without 501(c)(3) status (excluding institutions of higher education where relevant); for-profit organizations other than small businesses; small businesses; and other entities. The FOA also explicitly highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Historically Black Colleges and Universities (HBCUs), Hispanic-serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, regional organizations, U.S. territories or possessions, tribal governments that are not federally recognized, and even non-domestic (non-U.S.) entities (foreign organizations). This wide eligibility signals NIH's interest in attracting diverse investigators, settings, and populations, including communities that are often underrepresented in biomedical research.
Overall, the opportunity is aimed at improving the scientific foundation needed to understand and address substance-related problems through the lens of sex and gender, while also advancing research that directly benefits women. It encourages practical, hypothesis-driven projects that can uncover mechanisms, inform better-tailored prevention and treatment strategies, and ultimately reduce the burden of drug and alcohol use disorders across different populations.Apply for PA 18 601
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R03 Clinical Trial Optional)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.273, 93.279.
- This funding opportunity was created on 2018-01-29.
- Applicants must submit their applications by 2021-05-07. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $50,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same agency: National Institutes of Health
Browse more opportunities from the same category: Education, Health
Next opportunity: Limited Competition : HIV/AIDS-related Non-Human Primate Animal Research Facilities Restoration Program in the Aftermath of Hurricane Maria (C06 Clinical Trial Not Allowed)
Previous opportunity: Discovery and Biological Signatures of Diet Derived Microbial Metabolites (R01 Clinical Trial Optional)
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PA 18 601
Applicants also applied for:
Applicants who have applied for this opportunity (PA 18 601) also looked into and applied for these:
| Funding Opportunity |
|---|
| Women and Sex/Gender Differences in Drug and Alcohol Abuse/Dependence (R21 Clinical Trial Optional) Apply for PA 18 602 Funding Number: PA 18 602 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional) Apply for PAR 18 606 Funding Number: PAR 18 606 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Training Modules to Enhance the Rigor and Reproducibility of Biomedical Research (R25 Clinical Trial Not Allowed) Apply for RFA GM 18 002 Funding Number: RFA GM 18 002 Agency: National Institutes of Health Category: Education, Health Funding Amount: $250,000 |
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 Clinical Trial Optional) Apply for PAR 18 612 Funding Number: PAR 18 612 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 Clinical Trial Optional) Apply for PAR 18 611 Funding Number: PAR 18 611 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Mechanistic investigations of psychosocial stress effects on opioid use patterns (R01- Clinical Trial Optional) Apply for PAS 18 624 Funding Number: PAS 18 624 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Mechanistic investigations of psychosocial stress effects on opioid use patterns (R21- Clinical Trial Optional) Apply for PAS 18 625 Funding Number: PAS 18 625 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| NIDA Small Research Grant Program (R03 Clinical Trial Required) Apply for PA 18 626 Funding Number: PA 18 626 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| NIDA Academic Research Enhancement Award (R15, Clinical Trials Required) Apply for PA 18 627 Funding Number: PA 18 627 Agency: National Institutes of Health Category: Education, Health Funding Amount: $300,000 |
| Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Apply for PA 18 629 Funding Number: PA 18 629 Agency: National Institutes of Health Category: Education, Health Funding Amount: $499,999 |
| NIDA Small Research Grant Program (R03 Clinical Trial Required) Apply for PA 18 634 Funding Number: PA 18 634 Agency: National Institutes of Health Category: Education, Health Funding Amount: $50,000 |
| Innovative Approaches to Studying Cancer Communication in the New Media Environment (R01 - Clinical Trial Optional) Apply for PAR 18 638 Funding Number: PAR 18 638 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional) Apply for PAR 18 641 Funding Number: PAR 18 641 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional) Apply for PAR 18 640 Funding Number: PAR 18 640 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Time-Sensitive Research on Health Risk and Resilience after Hurricanes Irma and Maria in Puerto Rico and the US Virgin Islands (R21 Clinical Trial Not Allowed) Apply for RFA MD 18 006 Funding Number: RFA MD 18 006 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Innovative Approaches to Studying Cancer Communication in the New Media Environment (R21 - Clinical Trial Optional) Apply for PAR 18 639 Funding Number: PAR 18 639 Agency: National Institutes of Health Category: Education, Health Funding Amount: $200,000 |
| Research Infrastructure Development for Interdisciplinary Aging Studies (R21/R33 - Clinical Trial Optional) Apply for PAR 18 645 Funding Number: PAR 18 645 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 - Clinical Trial Optional) Apply for PAR 18 644 Funding Number: PAR 18 644 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Focused Technologies Toward Commercialization (R44 Clinical Trial Optional) Apply for RFA CA 18 011 Funding Number: RFA CA 18 011 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional) Apply for PA 18 651 Funding Number: PA 18 651 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PA 18 601", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
